Clinical trial

Epigenetics and NCD Prevention in Kazakhstan: Personalized Approaches and Biological Age Prediction

NCT06953180

Study summary

ClinicalTrials.gov

Epigenetics and NCD Prevention in Kazakhstan: Personalized Approaches and Biological Age Prediction

Design: OBSERVATIONAL · Status: RECRUITING · Phase: Not specified

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

OTHER · Unmapped registry intervention Genetic: DNA analysis Find medicine records · Find other trials using this name

StatusRECRUITING

Study typeOBSERVATIONAL

Start date2025-03-03

PhaseN/A

Conditions

Cardiovascular Diseases (CVD)unresolved

Type 2 Diabetesverified · MONDO: type 2 diabetes mellitus

Chronic Respiratory Diseasesunresolved

Obesity (Disorder)candidate · MONDO: obesity disorder

Chronic Kidney Diseasesunresolved

Interventions

Genetic: DNA analysisOTHER

Sponsors & collaborators

Asfendiyarov Kazakh National Medical Universitylead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06953180 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.